Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis

Podiatry Arena Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

16th March 2009, 02:30 PM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 3,060

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 5 Times in 5 Posts

Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis

Podiatry Arena members do not see these ads

Galderma Laboratories, L.P. announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex(R) (clobetasol propionate) Spray 0.05% followed by treatment with Vectical(TM) (calcitriol) Ointment 3mcg/g. The results of an interim analysis of the data are to be presented in a poster session at the 67th Annual Meeting of the American Academy of Dermatology on March 8th at 10:30 a.m. PT. The poster can be found under reference number 3362.

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is Off

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis	RSSFeedBot	Latest Dermatology News	0	7th March 2009 05:10 AM
Galderma Wins FDA Approval For Vectical(TM) Ointment, A Novel Topical Therapy For Mild-to-Moderate Plaque Psoriasis	RSSFeedBot	Latest Dermatology News	0	4th February 2009 05:30 AM
Synvista Therapeutics Announces First Dosing Of SYI-2074 In Clinical Trial For Psoriasis	RSSFeedBot	Latest Dermatology News	0	16th December 2008 07:30 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 11:56 AM.

User Name		Remember Me?
Password